Postpartum care differences in LGBTQ+ and non-LGBTQ+ individuals
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jul-2025 14:11 ET (22-Jul-2025 18:11 GMT/UTC)
Researchers at Sutter Health, led by Cheryl Stults, Ph.D., found that an innovative ambient artificial intelligence platform showed promising results in easing the burden of clinical documentation for healthcare providers. The study, published today in JAMA Network Open, revealed significant reductions in documentation time and improved overall clinician satisfaction. It also highlights the technology’s potential to address long-standing challenges in the medical profession.
Two HSS studies received awards from the American Society of Regional Anesthesia and Pain Medicine. One looked at the prevalence of CBD use in patients scheduled for sports medicine surgery. The other compared the need for opioid medication after robotic, computer-assisted or manual hip replacement.
Many mitochondrial diseases have been difficult to study and treat due to the inherent challenges in accessing mitochondrial DNA (mtDNA). Now, researchers from Japan have optimized mitochondrial-targeted compounds that can selectively modify the ratio of normal versus mutant mtDNA in patient-derived stem cells. This technology enables the creation of research models with varying mutation loads and demonstrates potential as a therapeutic strategy for reducing mutant mtDNA in patients, offering hope for mitochondrial disease treatment.
New research from Bayes Business School and biopharmaceuticals company Merck KGaA suggests member states from the European Union (EU) must work more closely together, provide better incentives for the development of new medicines and approve access to medicines quicker than other international regulators, if it is to attract greater investment from pharmaceutical companies.